Drugs
>> Sunday, 20 December 2009
Medical and science information
Influenza A (H1N1) 2009
Monovalent Vaccines Composition
and Lot Release
The four manufacturers will make the Influenza A (H1N1) 2009 Monovalent vaccines using the established manufacturing processes for their seasonal influenza vaccines. FDA approved these vaccines as a strain change to each manufacturer’s seasonal influenza vaccine. There is considerable experience with seasonal influenza vaccine development and production and influenza vaccines produced by this technology have a long and successful track record of safety and effectiveness in the United States. The Influenza A (H1N1) 2009 Monovalent vaccines will undergo the usual testing and lot release procedures that are in place for seasonal influenza vaccines.
Lot release information will be updated weekly. Last update: 12/16/2009.
| Manufacturer | Total Number of Lots Released by FDA |
|---|---|
| CSL Limited | 23 |
| MedImmune LLC | 62 |
| Novartis Vaccines and Diagnostics Limited | 56 |
| Sanofi Pasteur, Inc. | 97 |
http://medicalinformation-dobi.blogspot.com/search/label/Drugs

0 comments:
Post a Comment